Skip to main content
Top
Published in: Endocrine 1/2019

01-07-2019 | Bisphosphonate | Letter to the Editor

Long-term control of Paget’s disease of bone with low-dose, once-weekly, oral bisphosphonate preparations, in a “real world” setting

Authors: Yair Liel, Muhammad Abu Tailakh

Published in: Endocrine | Issue 1/2019

Login to get access

Excerpt

We thank Dr. Fu Sang et al. for their comments on our article on the control of Paget’s disease of bone with low dose weekly oral bisphosphonates [1]. …
Literature
1.
go back to reference Y. Liel, M. Abu Tailakh, Long-term control of Paget’s disease of bone with low-dose, once-weekly, oral bisphosphonate preparations, in a “real world” setting. Endocrine 63, 651–656 (2019)CrossRefPubMed Y. Liel, M. Abu Tailakh, Long-term control of Paget’s disease of bone with low-dose, once-weekly, oral bisphosphonate preparations, in a “real world” setting. Endocrine 63, 651–656 (2019)CrossRefPubMed
2.
go back to reference A.A. Al. Nofal, O. Altayar, K. BenKhadra, O.Q. Qasim Agha, N. Asi, M. Nabhan et al. Bone turnover markers in Paget’s disease of the bone: a systematic review and meta-analysis. Osteoporos. Int. 26, 1875–1891 (2015)CrossRefPubMed A.A. Al. Nofal, O. Altayar, K. BenKhadra, O.Q. Qasim Agha, N. Asi, M. Nabhan et al. Bone turnover markers in Paget’s disease of the bone: a systematic review and meta-analysis. Osteoporos. Int. 26, 1875–1891 (2015)CrossRefPubMed
Metadata
Title
Long-term control of Paget’s disease of bone with low-dose, once-weekly, oral bisphosphonate preparations, in a “real world” setting
Authors
Yair Liel
Muhammad Abu Tailakh
Publication date
01-07-2019
Publisher
Springer US
Published in
Endocrine / Issue 1/2019
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-01967-0

Other articles of this Issue 1/2019

Endocrine 1/2019 Go to the issue